Loading...
  Loading...
Employer Quick Look

Mallinckrodt

(Public)  
Pharmaceutical
5,000 - 10,000 employees  |  
Overview

Founded in 1867, Mallinckrodt, currently the pharmaceuticals business of Covidien, is a $2 billion global leader in providing products used in diagnostic procedures and in the treatment of pain and related conditions. Today, we are the largest U.S. supplier, by prescription, of opioid pain medications. We are a leading manufacturer of active pharmaceutical ingredients. And we are among the top 10 generic pharmaceutical companies in the U.S.

Our parent company, Covidien, is set to spin us off mid-2013 to become a standalone public company. Our separation will give our business greater flexibility to focus on and pursue our growth strategies, while potentially providing shareholders with greater value over the longer term.
Career Opportunities
Mallinckrodt offers a unique opportunity to grow your career in an established organization with an entrepreneurial feel and where you are empowered to earn more visibility, more quickly.  We offer diverse career paths so you can build skills and increase your value through unique experiences and meaningful assignments. No matter your place in our organization, you will play a key role as Mallinckrodt grows; your career grows with us.

More than 30 percent of hires are filled first with internal staff movement and/or promotions. And, you will be valued. Our comprehensive rewards programs are designed to recognize your contributions. From competitive salaries to work-life balance to personal praise from leadership, you truly share in the success you help create.
Mission
Mission: To reveal and relieve disease for a healthier world
 
Vision: A world made healthier by building on our heritage of distinctive capabilities to provide patients with pharmaceuticals that reveal and relieve disease

Core Values
: Quality, Integrity and Service
Contact Us
U.S. Headquarters

Mallinckrodt
675 McDonnell Blvd
Hazelwood, MO 63042
314-654-2000